MARKETS
Markets

Splash Beverage Expands Exclusive Global License For CannEpil To Include Veterinary Therapeutic Applications

Jul 29, 2026 · 08:33 AM ET· updated 2h ago

Splash Beverage Group, Inc. (NYSE:SBEV) ("Splash" or the "Company") today announced that it has expanded its exclusive global license for CannEpil® to include veterinary therapeutic applications,

Share
Why It Matters

Splash Beverage got permission to use CannEpil (a product with cannabis) for helping sick pets, not just people. This means the company might sell to a new group of customers, but we don't know yet if pet owners will actually buy it.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.